Stephens initiated coverage on TransMedics Group with a new price target

6/4/24 7:41:52 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Stephens initiated coverage of TransMedics Group with a rating of Overweight and set a new price target of $151.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TMDX

Date	Price Target	Rating	Analyst
12/17/2024	$116.00 → $75.00	Overweight → Neutral	Analyst
11/22/2024		Buy → Hold	Needham
10/29/2024	$200.00 → $125.00	Outperform	Oppenheimer
10/29/2024	$208.00 → $109.00	Buy	Needham
9/24/2024	$200.00	Outperform	Robert W. Baird
8/21/2024	$208.00	Buy	Needham
6/6/2024	$161.00	Overweight	Cantor Fitzgerald
6/4/2024	$151.00	Overweight	Stephens